• Selumetinib (SEMEDX) produced by BigBearPharma has been approved in Laos

  Vientiane, Laos - April 8, 2024 - BigBearPharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer thera···【Read More】

  Update: 04 Jun,2026Source: Haiou HealthViews: 73

• BigBear Pharma Announces Approval of Baricitinib (BARUDX) in Laos

  Vientiane, Laos - April 8, 2024 - BigBear Pharma, a leading biopharmaceutical company focused on the development and commercialization of innovative c···【Read More】

  Update: 03 Jun,2026Source: Haiou HealthViews: 80

• FDA Approves Zaynich (cefepime and zidebactam) for the Treatment of Complicated Urinary Tract Infections

  May 30, 2026 – Wockhardt announced that the U.S. Food and Drug Administration (FDA) has approved Zaynich (cefepime and zidebactam), a novel intravenou···【Read More】

  Update: 03 Jun,2026Source: Haiou HealthViews: 81

• Laos Big Bear Pharma: A New Force in Generic Drugs Rising from the Heart of Southeast Asia

  On the banks of the Mekong River in Laos, a transformation in healthcare accessibility is quietly taking place. As the Lao government continues to inc···【Read More】

  Update: 02 Jun,2026Source: Haiou HealthViews: 85

• BigBear Pharma Announces Approval of Larotrectinib (LARODX) in Laos

  Vientiane, Laos - May 30, 2024 - BIGBEARPharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer therap···【Read More】

  Update: 02 Jun,2026Source: Haiou HealthViews: 83

• BigBear Pharma Announces Approval of Adagrasib (ADADX) in Laos

  Vientiane, Laos – July 14, 2024 – BigBear Pharma, a leading biopharmaceutical company focused on the development and commercialization of innovative c···【Read More】

  Update: 01 Jun,2026Source: Haiou HealthViews: 87

• EMA Recommends Extending Indications for Decitabine /Cedazuridine

  On 23 April 2026, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommendi···【Read More】

  Update: 01 Jun,2026Source: Haiou HealthViews: 87

• Big Bear Pharmaceuticals : New Power of Southeast Asian Generics, Quality for Global Health

  When it comes to generic drugs, the first label that comes to many people's minds might be "India." However, as the global pharmaceutica···【Read More】

  Update: 29 May,2026Source: Haiou HealthViews: 104

• FDA Approves Use of Linzess (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)

  May 27, 2026 -- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life changing therapies for peop···【Read More】

  Update: 28 May,2026Source: Haiou HealthViews: 102

• FDA Approves Decnupaz (pivekimab sunirine-pvzy) for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

  May 27, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved Decnupaz (pivekimab sun···【Read More】

  Update: 28 May,2026Source: Haiou HealthViews: 104

• Tazemetostat (TAZEDX) manufactured by Big Bear Pharmaceutical has been approved in Laos

  Vientiane, Laos, August 01, 2024 – BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer tre···【Read More】

  Update: 27 May,2026Source: Haiou HealthViews: 102

• FDA approves the first all-oral combination regimen for patients with acute myeloid leukemia who cannot tolerate intensive induction chemotherapy

  On May 13, 2026, Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved decit···【Read More】

  Update: 27 May,2026Source: Haiou HealthViews: 101

• BigBear Pharma announces that Olaparib (OLADX) has been approved in Laos

  September 20, 2024 - Vientiane, Laos - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer···【Read More】

  Update: 26 May,2026Source: Haiou HealthViews: 109

• BigBearPharma announces that Letermovir (LETEDX) has been approved in Laos

  September 20, 2024 - Vientiane, Laos - BigBearPharma, a leading biopharmaceutical company focused on developing and commercializing innovative therapi···【Read More】

  Update: 26 May,2026Source: Haiou HealthViews: 193

• FDA Grants Accelerated Approval to Hepcludex (bulevirtide-gmod) Treatment for Chronic Hepatitis Delta Virus (HDV)

  FOSTER CITY, Calif.--(BUSINESS WIRE) May 22, 2026 -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (···【Read More】

  Update: 25 May,2026Source: Haiou HealthViews: 121